Pillstats
OTC · Tablet · Oral

Methenamine, Sodium Salicylate

Brands: Azo Urinary Tract Defense Antibacterial Protection · Cvs Antibacterial Plus Urinary Pain Relief · Cvs Dual Action Pain Relief · Cystex +12 · Methenamine + Sodium Salicylate

13 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US18 NDCs
13 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)9525
US makers13 labelers
Packages26
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.052$0.103$0.155$0.207Dec 2025Apr 2026Jul 2026
$0.178
Latest avg · Jul 22, 2026
+7%
Since Dec 17, 2025
13
Active US suppliers
42%
Top-2 supplier share*

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it13 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Clarion Brands LLCunknown8SUPPLYING
i-Health, Inc.unknown3SUPPLYING
CVS Pharmacyunknown2SUPPLYING
WALGREEN COMPANYunknown2SUPPLYING
Rising Pharma Holdings, Inc.unknown2SUPPLYING
Chain Drug Marketing Association Inc.unknown2SUPPLYING
Topco Associates LLCunknown1SUPPLYING
Cadence Health Incunknown1SUPPLYING
Meijer Distribution, Incunknown1SUPPLYING
Reese Pharmaceutical Counknown1SUPPLYING
Rite Aid Corporationunknown1SUPPLYING
AmerisourceBergen Drug Corporationunknown1SUPPLYING
Chain Drug Consortium, LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 24, 2022
    RECALLRecall (Class II): Cystex Urinary Pan Relief (NSAID) (methenamine 162mg, sodium salicylate 162.5mg tablets) packaged in a) 40-count bliste…

    cGMP deviations — Recalling firm: Ultra Seal Corporation — Nationwide within the United States